Dunsire Deborah 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jun 9, 2023
Insider Transaction Report
Form 4
Dunsire Deborah
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-07+7,110→ 7,110 totalExercise: $51.82Exp: 2033-06-07→ Common Stock (7,110 underlying) - Award
Common Stock
2023-06-07+3,860→ 19,730 total
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 7, 2024